Scientific Opinion on the substantiation of a health claim related to pantothenic acid and contribution to normal energy-yielding metabolism pursuant to Article 14 of Regulation (EC) No 1924/2006

Tabs

Article
Panel on Dietetic Products, Nutrition and Allergies
EFSA Journal
EFSA Journal 2013;11(10):3411 [10 pp.].
doi
10.2903/j.efsa.2013.3411
Panel members at the time of adoption
Carlo Agostoni, Roberto Berni Canani, Susan Fairweather-Tait, Marina Heinonen, Hannu Korhonen, Sébastien La Vieille, Rosangela Marchelli, Ambroise Martin, Androniki Naska, Monika Neuhäuser-Berthold, Grażyna Nowicka, Yolanda Sanz, Alfonso Siani, Anders Sjödin, Martin Stern, Sean (J.J.) Strain, Inge Tetens, Daniel Tomé, Dominique Turck and Hans Verhagen
Acknowledgements

The Panel wishes to thank the members of the Working Group on Claims: Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Marina Heinonen, Ambroise Martin, Hildegard Przyrembel, Yolanda Sanz, Alfonso Siani, Anders Sjödin, Sean (J.J.) Strain, Inge Tetens, Hendrik Van Loveren, Hans Verhagen and Peter Willatts for the preparatory work on this scientific opinion.

Contact
Type
Opinion of the Scientific Committee/Scientific Panel
On request from
Competent Authority of France following an application by Specialised Nutrition Europe (formerly IDACE)
Question Number
EFSA-Q-2008-186
Adopted
9 October 2013
Published in the EFSA Journal
25 October 2013
Affiliation
European Food Safety Authority (EFSA), Parma, Italy
Note
Abstract

Following an application from Specialised Nutrition Europe (formerly IDACE), submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to pantothenic acid and contribution to normal energy-yielding metabolism. The food constituent, pantothenic acid, which is the subject of the health claim, is sufficiently characterised. Contribution to normal energy-yielding metabolism is a beneficial physiological effect for infants and young children. A claim on pantothenic acid and normal energy-yielding metabolism in the general population has already been assessed with a favourable outcome. The Panel notes that the role of pantothenic acid in normal energy-yielding metabolism applies to all ages, including infants and young children (from birth to three years). The Panel concludes that a cause and effect relationship has been established between the dietary intake of pantothenic acid and contribution to normal energy-yielding metabolism.

Keywords
pantothenic acid, infants, children, energy-yielding metabolism, health claims
Print on demand
Number of Pages
10